6:18 PM
 | 
Oct 09, 2012
 |  BC Extra  |  Company News

Foundation Medicine, Eisai in genetic profiling deal

Foundation Medicine Inc. (Cambridge, Mass.) will conduct genomic profiling in an international clinical trial of an undisclosed cancer candidate...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >